by editor | Oct 5, 2015 | Buzz, Client News, Featured, Health, Health Stock
[cmwizard menu=avxlmenu title=”Full Coverage AVXL”/]A stock that has been moving up and up lately is Anavex Life Sciences Corp. (OTCQX: AVXL). Shares closed up today 18.44% on very strong volume. Here is some of what we heard on Twitter Today: $AVXL...
by GlobeNewsWire | Sep 28, 2015 | Globe Newswire
NEW YORK, Sept. 28, 2015 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (OTCQX:AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s disease, other central nervous system (CNS) diseases,...
by GlobeNewsWire | Sep 23, 2015 | Globe Newswire
NEW YORK, Sept. 23, 2015 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (OTCQX:AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s disease, other central nervous system (CNS) diseases,...
by GlobeNewsWire | Sep 22, 2015 | Globe Newswire
BOSTON, Sept. 22, 2015 (GLOBE NEWSWIRE) — LogMeIn Inc.’s (NASDAQ:LOGM) Internet of Things (IoT) platform, Xively, was named the IoT Innovative Technology of the Year winner by the Massachusetts Technology Leadership Council (MassTLC) during the 2015...
by GlobeNewsWire | Sep 21, 2015 | Globe Newswire
NEW YORK, Sept. 21, 2015 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (OTCQX:AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s disease, other central nervous system (CNS) diseases,...